Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Tonix Pharmaceuticals Holding Corp
TNXP
Healthcare
Biotechnology
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg. Its portfolio consists of central nervous system (CNS), rare disease, immunology, and...
infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases and cancer. Its infectious disease portfolio includes a vaccine in development to prevent smallpox and mpox, vaccines to prevent COVID-19, a platform to make fully human monoclonal antibodies (mAbs), to treat COVID-19 and humanized anti-SARS-CoV-2 mAbs. Its product candidates include TNX-102 SL, TNX-4300, TNX-1900, TNX-601 ER and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TNXP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 13, 2023 3:43am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(81)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 02, 2023 12:25pm
TNXP..... NR's after the open
Seldom workout ; )
Oil & Gas Co. Surpasses Expectations: Spearheading Success in the Oxbow Area and More for 2023
posted Sep 21, 2023 9:00am by
Saturn Oil & Gas Inc.
-
|
"Our Spearfish light oil drilling program has generated capital efficiencies that are among the strongest we've seen across our asset base, and have outperformed our internal expectations, which confirms the extensive multizone development opportunities offered by our Oxbow asset ...read more
(0)
•••
EllaMae
X
Post by
EllaMae
on Jul 15, 2022 9:20pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
EllaMae
X
Post by
EllaMae
on Jun 03, 2022 5:04am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
EllaMae
X
Post by
EllaMae
on Jun 02, 2022 12:16am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
EllaMae
X
Post by
EllaMae
on May 11, 2022 1:25am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 30, 2022 10:45pm
FSD Pharma Inc: Lucid MS Video
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 23, 2022 2:23am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 16, 2022 3:37am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 09, 2022 2:45am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 07, 2022 12:16pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Apr 06, 2022 1:40am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Feb 19, 2022 1:40am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(0)
•••
EllaMae
X
Post by
EllaMae
on Feb 04, 2022 10:41am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Jan 01, 2022 12:41am
FSD Pharma Announces Share Repurchase Program
FSD Pharma Announces Share Repurchase Program TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Bob Moriarty: Lithium South (TSXV:LIS) is a Real Deal Lithium Company
Company Announces Name Change as They Turn Full Focus to Gold
SolarBank Completes Sale of 21MW Community Solar Sites to Honeywell International for $41mn
A Digital Advertising Company Announces Updated Commercial Agreements with Large National Retailers